United Therapeutics
UTHR
554.73
-4.37
-0.78%
United Therapeutics
US · UTHR
#836 by market cap
Listed 1970
554.73
-4.37
-0.78%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: BTIG moved from Hold to Buy on 2026-10-01.
Analyst consensus 14 analysts
Buy
Avg price target 682.57 +23.0%
Price target rangecurrent 554.73
Low368.00
Avg682.57
High850.00
Buy 79%
Hold 14%
Sell 7%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-09 | H.C. Wainwright | -- | Buy | 660.00 |
| 2026-11-05 | TD Cowen | -- | Buy | 700.00 |
| 2026-11-05 | Wells Fargo | -- | Buy | 703.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 725.00 |
| 2026-11-04 | Wells Fargo | -- | Buy | 703.00 |
| 2026-11-04 | BTIG | -- | Buy | 768.00 |
| 2026-11-04 | BofA Securities | -- | Hold | 650.00 |
| 2026-11-04 | RBC Capital | -- | Buy | 725.00 |
| 2026-10-28 | J.P. Morgan | -- | Buy | 695.00 |
| 2026-10-26 | Cantor Fitzgerald | -- | Buy | 850.00 |
| 2026-10-22 | RBC Capital | -- | Buy | 697.00 |
| 2026-10-20 | Raymond James | -- | Buy | 717.00 |
| 2026-10-20 | Leerink Partners | -- | Buy | 725.00 |
| 2026-10-19 | Leerink Partners | -- | Buy | 725.00 |
| 2026-10-16 | Wells Fargo | -- | Buy | 700.00 |
| 2026-10-15 | Goldman Sachs | -- | Sell | 368.00 |
| 2026-10-13 | UBS | -- | Buy | 725.00 |
| 2026-10-12 | Leerink Partners | -- | Buy | 685.00 |
| 2026-10-09 | BofA Securities | -- | Hold | 559.00 |
| 2026-10-08 | RBC Capital | -- | Buy | 708.00 |
| 2026-10-08 | J.P. Morgan | -- | Buy | 710.00 |
| 2026-10-07 | Morgan Stanley | -- | Hold | 566.00 |
| 2026-10-01 | BTIG | -- | Buy | 728.00 |
| 2026-10-01 | Jefferies | -- | Buy | 704.00 |
| 2026-10-01 | Leerink Partners | -- | Buy | 685.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-01 | BTIG | Hold → Buy | 728.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | -- | ±6.59% | +1.19% (in line) |
| 2026/Q2 | 2026-08-05 | -- | ±6.41% | +0.06% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±7.62% | +4.29% (in line) |
| 2025/Q4 | 2026-02-25 | -- | ±9.13% | +13.03% (beat) |
| 2025/Q3 | 2025-10-29 | -- | ±9.93% | +9.63% (in line) |
| 2025/Q2 | 2025-07-30 | -- | ±9.47% | -5.25% (in line) |
| 2025/Q1 | 2025-04-30 | -- | ±7.44% | +0.77% (in line) |
| 2024/Q4 | 2025-02-26 | -- | ±9.10% | -10.80% (beat) |
| 2024/Q3 | 2024-10-30 | -- | ±7.37% | +2.44% (in line) |
| 2024/Q2 | 2024-07-31 | -- | ±7.97% | -7.18% (in line) |
| 2024/Q1 | 2024-05-01 | -- | ±8.20% | +8.88% (beat) |
| 2023/Q4 | 2024-02-21 | -- | ±8.78% | +2.34% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:22 · For reference only, not investment advice and not tailored to your situation.
United Therapeutics discussion 0 comments